1. Home
  2. TECX vs HIX Comparison

TECX vs HIX Comparison

Compare TECX & HIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$20.05

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

Logo Western Asset High Income Fund II Inc.

HIX

Western Asset High Income Fund II Inc.

SELL

Current Price

$3.35

Market Cap

351.3M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
TECX
HIX
Founded
2019
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
351.3M
IPO Year
2018
1998

Fundamental Metrics

Financial Performance
Metric
TECX
HIX
Price
$20.05
$3.35
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $71.00
N/A
AVG Volume (30 Days)
223.0K
★ 424.9K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
★ 13.14%
EPS Growth
★ 40.70
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.60
$3.41
52 Week High
$39.53
$4.33

Technical Indicators

Market Signals
Indicator
TECX
HIX
Relative Strength Index (RSI) 29.83 25.59
Support Level $17.27 N/A
Resistance Level $23.61 $4.04
Average True Range (ATR) 1.20 0.04
MACD 0.17 0.00
Stochastic Oscillator 7.40 2.63

Price Performance

Historical Comparison
TECX
HIX

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About HIX Western Asset High Income Fund II Inc.

Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its primary investment objective is to maximize current income by investing at least 80% of its net assets, plus any borrowings for investment purposes, in high-yield debt securities. As a secondary objective, the Fund seeks capital appreciation to the extent consistent with its objective of seeking to maximize current income.

Share on Social Networks: